An effective CTL peptide vaccine for Ebola Zaire Based on Survivors' CD8+targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design (2020)
- Authors:
- Autor USP: CUNHA NETO, EDECIO - FM
- Unidade: FM
- DOI: 10.1016/j.vaccine.2020.04.034
- Subjects: EPITOPOS; IMUNIDADE; MORBIDADE; VACINAÇÃO; SOBREVIDA; COVID-19
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- Versão do Documento: Versão publicada (Published version)
-
Status: Artigo aberto em periódico híbrido (Hybrid Open Access) -
ABNT
V, C. Herst et al. An effective CTL peptide vaccine for Ebola Zaire Based on Survivors' CD8+targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design. Vaccine, v. 38, n. 28, p. 4464-4475, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2020.04.034. Acesso em: 17 mar. 2026. -
APA
V, C. H., Burkholz, S., Sidney, J., Sette, A., Harris, P. E., Massey, S., et al. (2020). An effective CTL peptide vaccine for Ebola Zaire Based on Survivors' CD8+targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design. Vaccine, 38( 28), 4464-4475. doi:10.1016/j.vaccine.2020.04.034 -
NLM
V CH, Burkholz S, Sidney J, Sette A, Harris PE, Massey S, Brasel T, Cunha Neto E, Rosa DS, Chao WCH. An effective CTL peptide vaccine for Ebola Zaire Based on Survivors' CD8+targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design [Internet]. Vaccine. 2020 ; 38( 28): 4464-4475.[citado 2026 mar. 17 ] Available from: https://doi.org/10.1016/j.vaccine.2020.04.034 -
Vancouver
V CH, Burkholz S, Sidney J, Sette A, Harris PE, Massey S, Brasel T, Cunha Neto E, Rosa DS, Chao WCH. An effective CTL peptide vaccine for Ebola Zaire Based on Survivors' CD8+targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design [Internet]. Vaccine. 2020 ; 38( 28): 4464-4475.[citado 2026 mar. 17 ] Available from: https://doi.org/10.1016/j.vaccine.2020.04.034 - Increased expression of circulating microRNA 101-3p in type 1 diabetes patients: new insights into miRNA-regulated pathophysiological pathways for type 1 diabetes
- Chagas Disease Cardiomyopathy: Immunopathology and Genetics
- Exosomes from patients with septic shock convey miRNAs related to inflammation and cell cycle regulation: new signaling pathways in sepsis?
- Imunodeficiências secundária
- Evaluation of the profile of circulating microRNAs in individuals with recent type 1 diabetes and healthy controls
- CD4+ T Cell Epitope Discovery and Rational Vaccine Design
- Linfócitos T
- Sm14 cell epitopes immunization induces protective immunity against schistosoma mansoni infection in mice
- Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice
- Immunology and Infection by Protozoan Parasites [Editorial]
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
